|
|
|
|
 |
 |
Home
> Products > Áø´Ü»ç¾÷ / Publication List |
 |
|
 |
|
 |
|
|
|
(1) |
±èÁÖÇü, ±è¿µ¹è, ÃÖÁøÇõ, ±èÁ¤¹Ì, Á¤¼öÇö, ¼±¤¿í. ´ëÀå¾ÏÀÇ ¿¹ÈÄÀÎÀڷμ thymidylate synthase À¯ÀüÀÚ ´ÙÇü¼ºÀÇ ÀÇÀÇ. ´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö. 2004; 20(3):151-156.
[Abstract]
[PDF] |
|
|
(2) |
Han SW, Kim TY, Hwang PG, Jeong S, Kim J, Choi IS, Oh DY, Kim JH, Kim DW, Chung DH, Im SA, Kim YT, Lee JS, Heo DS, Bang YJ, Kim NK. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol. 2005; 23(11):2493-2501.
[Abstract] |
|
|
(3) |
Shin Myung Kang, Moo Suk Park, Joon Chang, Se Kyu Kim, Haeryoung Kim, Dong-Hwan Shin, Kyung Young Chung, Dae Joon Kim, Joo Hyuk Sohn, Sung Ho Choi, Jeongmi Kim, Eun Jin Yoon, Joo-Hang Kim. A Feasibility Study of Adenosine Triphosphate BasedChemotherapy Response Assay (ATP-CRA)as a Chemosensitivity Test for Lung Cancer. Cancer Research and Treatment. 2005; 37(4): 223-227.[Abstract]
[PDF] |
|
|
(4) |
Yoon DS, Park YN, Seo SJ, Ahn SP, Park JS, Chi HS. Putative Tumor Suppressor Gene Loci onChromosome 20q in Intrahepatic Cholangiocellular Carcinoma that were Found by Microsatellite Marker Analysis. Korean J Hepatobiliary Pancreat Surg. 2006;10(2):29-33.
[Abstract] |
|
|
(5) |
Kwang Wook Suh, Joo Hyung Kim,Do Yoon Kim,Young Bae Kim Chulho Lee and Sung Ho Choi. Which Gene is a Dominant Predictor of Response During FOLFOX Chemotherapy for the Treatment of Metastatic Colorectal Cancer, the MTHFR or XRCC1 Gene? ANNALS OF SURGICAL ONCOLOGY. 2006; 13(11):1379-1385.
[Abstract] |
|
|
(6) |
¿À½Â¿±, ÀÌÀ縸, ÀÌÈ£¿ø, ±è¿µ¹è, Á¤¼öÇö, ±èÁ¤¹Ì, ¼±¤¿í. »ê¹ß¼º ´ëÀå¾Ï¿¡¼ Çö¹ÌºÎ¼öü ºÒ¾ÈÁ¤¼ºÀÇ ÀÓ»óº´¸®ÇÐÀû ÀÇÀÇ. ´ëÇѿܰúÇÐȸÁö. 2006; 71(6):420-425.
[Abstract]
[PDF] |
|
|
(7) |
Hyun-Ah Kim ,Cha-Kyong Yom ,Byung-In Moon ,Kuk-Jin Choe, Sun-Hee Sung, Woon-Sup Han ,Hye-Young Choi ,Hye-Kyoung Kim, Heung-Kyu Park, Sung-Ho Choi ,Eun-Jin Yoon, Soo-Youn Oh. The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer. BREAST. 2007; 17(1):19-26.
[Abstract] |
|
|
(8) |
ÇãÁ¤¿í, ¹ÚÀ±¾Æ, ¼Õ½Â±¹, ÃÖ¼ºÈ£. ´ëÀå¾Ï¿¡¼ Adenosine triphosphate based Chemotherapy ResponseAssay (ATP-CRA)¸¦ ÀÌ¿ëÇÑ In-vitro Ç×¾ÏÁ¦ °¨¼ö¼º °Ë»ç. ´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö. 2007; 23(3):172-179.
[Abstract]
[PDF] |
|
|
(9) |
¹ÚÂù¼·, ÃÖ¼ºÈ£, ±èÈï´ë. ´ëÀå¾Ï¿¡¼ Ç×¾ÏÁ¦ °¨¼ö¼º °Ë»çÀÇ ÀÓ»óÀû Ư¼º¿¡ °üÇÑ Ãʱ⿬±¸. ´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö. 2007; 23(5):358-364.
[Abstract]
[PDF] |
|
|
(10) |
SU Woo, JW Bae, HG Kim, SH Choi, DH Kang, JB Lee, BW Koo. Correlation between the in vito ATP-based chemosensitivity assay and HER2/neu expression in women with breast cancer. The Journal of International Medical Research. 2007;35 (6):753-761.
[Abstract] |
|
|
(11) |
¼³¹Ì¿µ, ÃÖ°æ¿î, ±èÁö¿¬, °ÇöÁ¤, ½Åµ¿ÈÆ, ±èÀ͵Î, ÃÖÈ¿¼±, ¼¼øÁ¤. ³¼Ò»óÇǾϿ¡¼ Çö¹ÌºÎ¼öü ºÒ¾ÈÁ¤¼º ºÐ¼®. ´ëÇѺ´¸®ÇÐȸÁö. 2007; 41:380-386.
[Abstract]
[PDF] |
|
|
(12) |
YW Moon, SH Choi, YT Kim, JH Sohn, J Chang, SK Kim, MS Park, KY Chung, HJ Lee, JH Kim. Adenosine Triphosphate-Based Chemotherapy Response Assay (ATP-CRA)-guided Platinum-Based 2-Drug Chemotherapy for Unresectable Nonsmall-cellLung Cancer. CANCER. 2007;109(9):1829-1835.
[Abstract]
[PDF] |
|
|
(13) |
Huh JW, Park YA, Jung EJ, Lee KY, Kwon JE, Sohn SK. Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay. J Korean Med Sci. 2008;23(5):916-919.
[Abstract]
[PDF] |
|
|
(14) |
Seung-Su Han, Sung Ho Choi, Yoo-Kyung Lee, Jae Weon Kim, Noh-Hyun Park, Yong-Sang Song, Hyo-Pyo Lee,Soon-Beom Kang. Predictive Value of Individualized Tumor Response Testing by ATP-Based Chemotherapy Response Assay in Ovarian Cancer. CANCER INVESTIGATION. 2008;26:426-430.
[Abstract] |
|
|
(15) |
JY Park, Y S Kim, SM Bang, WJ Hyung, SH Noh, SH Choi, SY Song. ATP-Based Chemotherapy Response Assay in Patients with Unresectable Gastric Cancer. ONCOLOGY. 2008;73:439-440.
[No
abstract available] |
|
|
(16) |
Jang TW, Oak CH, Chang HK, Suo SJ, Jung MH. EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung. Korean J Intern Med. 2009;24 (1):48-54.
[Abstract]
[PDF] |
|
|
(17) |
Koo JS, Jung W, Shin E, Lee HD,
Jeong J, Kim KH, Jeong H, Hong
SW. Impact of grade, hormone
receptor, and HER-2 status in
women with breast cancer on
response to specific
chemotherapeutic agents by in
vitro adenosine triphosphate-based
chemotherapy response assay. J
Korean Med Sci.
2009;24(6):1150-1157.
[Abstract]
[PDF] |
|
|
(18) |
Moon YW, Sohn JH, Kim YT, Chang
H, Jeong JH, Lee YJ, Chang J,
Kim SK, Jung M, Hong S, Choi SH,
Kim JH. Adenosine triphosphate-based
chemotherapy response assay
(ATP-CRA)-guided versus
empirical chemotherapy in
unresectable non-small cell lung
cancer. Anticancer Res.
2009;29(10):4243-4249.
[Abstract] |
|
|
(19) |
Y.B. Cho, W.Y. Lee, S.Y. Song, S.H. Choi, H.J. Shin, K.-D. Ahn, J.M. Lee, H.C. Kim, S.H. Yun, H.-K. Chun.In vitro chemosensitivity based on depth of invasion in advanced colorectal cancer using ATP-based chemotherapy response assay (ATP-CRA). Eur J Surg Oncol. 2009;35(9):951-956.
[Abstract] |
|
|
(20) |
Koo JS, Jung W, Jeong J. The Predictive Role of E-cadherin and Androgen Receptor on In Vitro Chemosensitivity in Triple Negative Breast Cancer. Jpn J Clin Oncol. 2009;39(9):560-568.
[Abstract] |
| ¡¡ |
|
(21) |
Young Joo Lee, In Kyu Park, Moo-Suk
Park, Hye Jin Choi, Byoung Chul
Cho,, Kyung Young Chung, Se Kyu
Kim, Joon Chang, Jin Wook Moon,
Hoguen Kim, Sung Ho Choi, Joo-Hang
Kim. Activating mutations within
the EGFR kinase domain: a
molecular predictor of
disease-free survival in
resected pulmonary
adenocarcinoma. J Cancer Res
Clin Oncol.
2009;135(12):1647-1654.
[Abstract] |
|
|
(22) |
Park S, Woo Y, Kim H, Lee YC,
Choi S, Hyung WJ, Noh SH. In
Vitro Adenosine Triphosphate
Based Chemotherapy Response
Assay in Gastric Cancer. J
Gastric Cancer.
2010;10(4):155-161.
[Abstract]
[PDF] |
|
|
(23) |
Hur H, Kang J, Kim NK, Min BS,
Lee KY, Shin SJ, Keum KC, Choi
J, Kim H, Choi SH, Lee MY.
Thymidylate Synthase Gene
Polymorphism Affects the
Response to Preoperative
5-Fluorouracil Chemoradiation
Therapy in Patients With Rectal
Cancer. Int J Radiat Oncol Biol
Phys. 2010 Oct 5. Epub ahead of
print (PMID 20932673)
[Abstract]
|
|
|
(24) |
ÃÖ¼ºÈ£, ±èºÀ¼®. Ç×¾ÏÁ¦¹ÝÀÀ¼º°Ë»ç: °³¿ä, ¹æ¹ý·Ð ¹×
ATP-CRA¸¦ Ȱ¿ëÇÑ Àӻ󿬱¸°á°ú.
BioWave.12(9) 2010
[Abstract]
[PDF] |
|
|
(25) |
Choi SK, Jeong J, Lee SA, Hwang
SH, Ahn SG, Jung WH, Lee HD.
Heterogeneous Chemosensitivity
of Breast Cancer Determined by
Adeonsine Triphosphate Based
Chemotherapy Response Assay. J
Breast Cancer.
2010;13(3):323-323.
[Abstract]
[PDF] |
|
|
(26) |
Lee YJ, Cho BC, Jee SH, Moon JW,
Kim SK, Chang J, Chung KY, Park
IK, Choi SH, Kim JH. Impact of
environmental tobacco smoke on
the incidence of mutations in
epidermal growth factor receptor
gene in never-smoker patients
with non-small-cell lung cancer.
J Clin Oncol. 2010;28(3):487-492.
[Abstract] |
|
|
(27) |
Ahn SG, Jeong J, Choi SK, Hwang
SH, Lee SA, Jung WH, Lee HD.
Correlation of Early Systemic
Recurrence with In Vitro
Adenosine Triphosphate-Based
Chemotherapy Response Assay in
Stage II and III Breast Cancer
Patients Treated with
Doxorubicin-Based Chemotherapy.
J Breast Cancer. 2011;14(Suppl
1):S50-S56.
[Abstract]
[PDF] |
|
|
(28) |
Lee JH, Kim MC, Oh SY, Kwon HC,
Kim SH, Kwon KA, Lee S, Jeong
JS, Choi SR, Kim HJ. Predictive
Value of In Vitro Adenosine
Triphosphate-Based Chemotherapy
Response Assay in Advanced
Gastric Cancer Patients Who
Received Oral 5-Fluorouracil
after Curative Resection. Cancer
Res Treat. 2011;43(2):117-123.
[Abstract]
[PDF] |
|
|
|
|
|
|
|
|
| ¡¡ |
|
|
|
|
| ¡¡ |
|